Key facts
- This page summarizes David Allen Jones Jr.'s Form 4 filing for HUMANA INC (HUM).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Apr 2023, 10:58.
David Allen Jones Jr. - 20 Apr 2023 Form 4 Insider Report for HUMANA INC (HUM)
- Reporting relationship
- Director
- Issuer ticker
- HUM
- Reported as of
- 20 Apr 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Apr 2023, 10:58:36 UTC
- Prior SEC filing
- 02 Mar 2023
- Next SEC filing
- 02 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- David A. Jones, Jr.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Allen Jones Jr. filed Form 4 for HUMANA INC (HUM) on 20 Apr 2023.
Change
- Previous filing in this sequence was filed on 02 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HUM
holding
Humana Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 380
- Date
- 20 Apr 2023
- Ownership
- Direct
- Footnotes
- F5
HUM
holding
Humana Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 800
- Date
- 20 Apr 2023
- Ownership
- See Footnote
- Footnotes
- F1
HUM
holding
Humana Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 32,440
- Date
- 20 Apr 2023
- Ownership
- See Footnote
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,892
- Date
- 20 Apr 2023
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 5,892
- Exercise price
- Footnotes
- F2
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 95
- Date
- 20 Apr 2023
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 95
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
David Allen Jones Jr. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 5 footnotes
Footnote F1
Shares held in two trusts for the benefit of reporting person's son/daughter, respectively, in each case where the reporting person is the sole trustee.
Footnote F2
Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
Footnote F3
Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
Footnote F4
Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock.
Footnote F5
Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/23. Total shares received will be pro-rated based on number of months served on the Board prior to separation.